Insider Transactions in Q3 2021 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2021
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
848
-2.67%
|
$93,280
$110.01 P/Share
|
|
Sep 23
2021
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
848
+2.6%
|
$30,528
$36.05 P/Share
|
|
Sep 23
2021
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
25,000
-16.2%
|
$2,700,000
$108.78 P/Share
|
|
Sep 23
2021
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+30.02%
|
$700,000
$28.36 P/Share
|
|
Sep 23
2021
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
600
-5.61%
|
$66,000
$110.0 P/Share
|
|
Sep 23
2021
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+5.31%
|
$9,000
$15.01 P/Share
|
|
Sep 15
2021
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,833
-8.7%
|
$1,183,300
$100.52 P/Share
|
|
Sep 15
2021
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+18.71%
|
$577,500
$66.24 P/Share
|
|
Sep 13
2021
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-0.37%
|
$99,000
$99.27 P/Share
|
|
Sep 13
2021
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+1.79%
|
$36,000
$36.05 P/Share
|
|
Sep 13
2021
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
600
-5.61%
|
$60,000
$100.0 P/Share
|
|
Sep 13
2021
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+5.31%
|
$9,000
$15.01 P/Share
|
|
Aug 26
2021
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+7.83%
|
$16,000
$1.87 P/Share
|
|
Aug 19
2021
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
25,000
-6.54%
|
$2,300,000
$92.61 P/Share
|
|
Aug 19
2021
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+6.07%
|
$200,000
$8.44 P/Share
|
|
Aug 17
2021
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,350
-11.79%
|
$122,850
$91.93 P/Share
|
|
Aug 17
2021
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,350
+5.73%
|
$6,750
$5.34 P/Share
|
|
Jul 13
2021
|
George Demetri |
BUY
Open market or private purchase
|
Direct |
10
+0.17%
|
$820
$82.66 P/Share
|